Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies

Conditions

• Hematologic Malignancy
• Acute Leukemia
• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Acute Biphenotypic Leukemia
• Acute Undifferentiated Leukemia
• CLL (Chronic Lymphocytic Leukemia)
• Chronic Myeloid Leukemia
• MDS (Myelodysplastic Syndrome)
• Non Hodgkin Lymphoma
• Hodgkin Lymphoma
• Cutaneous T Cell Lymphomas (CTCL)

Interventions

• OTHER: Ossium HPC, Marrow
• OTHER: Standard of care living donor - Haplo Related
• OTHER: Standard of care living donor - Mismatched Unrelated

Sponsor

Ossium Health, Inc.